Meera Mehta

353 POSTS
Meera is our dedicated writer and manager for the AI Stocks category. With her expertise in finance and a deep interest in the AI industry, Meera keeps a close eye on AI-related stocks and market trends. Her articles provide valuable insights into the financial aspects of AI, helping investors navigate this exciting and dynamic sector.

Exclusive articles:

Is the AI Stock Boom a Dot-Com-Style Bubble? Insights from 7 Experts

Discover whether the current AI stock boom is reminiscent of the dot-com bubble. Some experts claim similarities while others disagree. Learn more here.

Desperate to Retire? These 3 AI Stocks Can Help Secure Your Future

Investors worried about retirement prospects can balance safety with growth potential by considering high-growth AI stocks like Duolingo, Lemonade, and Shopify. These stocks offer long-term growth potential and AI-powered innovation for investors looking to invest wisely.

3 Questions Investors Should Ask Before Buying AI Stocks

Investing in AI stocks may seem like the latest trend, but it's not for everyone. Before jumping in, consider valuation, investment horizon, and whether AI is a game-changer or a fad. Proceed with caution.

2 Popular AI Stocks That Are Hot Right Now, But I’m Not Investing – Here’s Why

Investors, beware of these two popular AI stocks: Nvidia faces competition, high pricing, and overvaluation, while C3.ai has a broken business model with a high price-to-sales ratio. Be cautious and do your research before investing.

Morgan Stanley Picks Nvidia as Top AI Stock, Cautions of Potential Market Headwinds from AI-Driven Rally

Investment bank Morgan Stanley recommends Nvidia over AMD as its top tech pick. Nvidia is poised for growth in the AI sector, according to analysts.

Breaking

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.
spot_imgspot_img